S 2944
108th Congress
Senate
Foreign Trade and International Finance
AIDS (Disease)
Clinical trials
Commerce
Drug approvals
Drug industry
Drugs
Emergency Management
Emergency medicine
Epidemics
Generic drugs
Government Operations and Politics
Health
Human immunodeficiency viruses
International Affairs
Malaria
Office of the U.S. Trade Representative
Trade agreements
Trade negotiations
Tuberculosis
A bill to provide that no funds may be expended by the United States Trade Representative to negotiate data exclusivity provisions for certain pharmaceutical products.
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 8, 2004
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10848)
Oct 8, 2004
Sponsor introductory remarks on measure. (CR S10847-10848)
Oct 8, 2004
Introduced in Senate
Plain-English summary
Prohibits funds appropriated or otherwise obligated to the U.S. Trade Representative from being expended to negotiate data exclusivity provisions with any country with respect to public health pharmaceutical products or to require actions of another country which interfere with a country's access to such products.
What's happening now
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10848)
Committees of jurisdiction
1